Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

Registrati

Quotazioni in diretta

IPSC Century Therapeutics Inc

1,24

-0,02 (-1,59%)

Ultimo aggiornamento: 15:57:00

Dati in Delay di 15 minuti

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.

Date of Notice

08/05/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Adrienne Farid

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Grafico Azioni Century Therapeutics (NASDAQ:IPSC)
Storico
Da Ott 2024 a Nov 2024

Clicca qui per i Grafici di Century Therapeutics

Grafico Azioni Century Therapeutics (NASDAQ:IPSC)
Storico
Da Nov 2023 a Nov 2024

Clicca qui per i Grafici di Century Therapeutics

Notizie Century Therapeutics Inc - IPSC

Form 4 - Statement of changes in beneficial ownership of securities
Martedì 5 Novembre 2024 (1 settimana fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Martedì 5 Novembre 2024 (1 settimana fa) • Edgar (US Regulatory)

Form 8-K - Current report
Martedì 5 Novembre 2024 (1 settimana fa) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Martedì 5 Novembre 2024 (1 settimana fa) • Edgar (US Regulatory)

Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
Martedì 5 Novembre 2024 (1 settimana fa) • GlobeNewswire Inc.

Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting
Martedì 5 Novembre 2024 (1 settimana fa) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Lunedì 4 Novembre 2024 (2 settimane fa) • Edgar (US Regulatory)

Century Therapeutics to Present at Guggenheim’s Inaugural Healthcare Innovation Conference
Lunedì 4 Novembre 2024 (2 settimane fa) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sabatp 26 Ottobre 2024 (3 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 16 Ottobre 2024 (4 settimane fa) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Mercoledì 16 Ottobre 2024 (4 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Venerdì 4 Ottobre 2024 (1 mese fa) • Edgar (US Regulatory)

Più Century Therapeutics Inc Articoli Notizie

Intesa Sanpaolo

ST Microelectronics

Banca Monte Dei Paschi D...

Mediobanca Banca di Cred...

Delayed Upgrade Clock

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea